Simulation of intratumoral release of Etanidazole: Effects of the size of surgical opening

Journal of Pharmaceutical Sciences

Volumn 92, Issue 4, 2003, Pages 773-789

  Tan, Wilson Hor Keong ^a   Lee, Timothy ^a   Wang, Chi Hwa ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE MIT ALLIANCE   (Singapore)

Author keywords

Brain tumor; Drug delivery; Etanidazole; Radiosensitizer; Simulation

Indexed keywords

ETANIDAZOLE; POLYMER; RADIOSENSITIZING AGENT;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG PENETRATION; EDEMA; GEOMETRY; IMPLANTATION; MATHEMATICAL MODEL; SIMULATION; SURGICAL TECHNIQUE; TISSUE PRESSURE; TISSUE SECTION; TOXICITY; VELOCITY;

EID: 0037381372     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10351     Document Type: Article

References (34)

1. Wong KH, Wallen CA, Wheeler KT. 1999. Chemosensitization of the Nitrosoureas by 2-Nitroinidazoles in the subcutaneous 9L tumor model: Pharmacokinetic and structural-activity considerations. I. J Radiat Oncol 18:1043-1050.
2. O'Dwyer PJ, LaCreta FP, Walczak J, Cox T, Litwin S, Hoffman JP, Zimny M, Comis RL. 1993. Phase I pharmacokinetic/biochemical study of the nitroimidazoles hypoxic cell sensitizer SR2508 (etanidazole) in combination with cyclophosphamide. Br J Cancer 68:756-766.
3. Rowinsky EK. 1999. Novel radiation sensitizers targeting tissue hypoxia. Oncology 13(10;Suppl 5):61-70.
4. Lee WW, Brwon JM, Martinez AP, Cory MJ. 1983. Nitroimidazoles of low toxicity and high activity as radiosensitizers of hypoxic tumor cells. U.S. Pat. 4371540.
5. Dabrow MB, Katz H, O'Dwyer PJ, Afshar C, Glusker JP. 1993. Molecular dimension and properties of N-[1-(2-Hydroxyethyl)-2-nitro-1H-immidazole-1-yl]acetamide (SR2508). Arch Biochem Biophys 302(1):259-264.
6. Reise NE, Loeffler JS, Wen P, Alexander E, Black PM, Coleman CN. 1994. A phase I study of etanidazole and radiotherapy in malignant glioma. Int J Radiat Oncol Biol Phys 29(3):617-620.
7. Skov KA, Macphail S. 1994. Low concentration of nitroimidazoles: Effective radiosensitizers at low doses. Int J Radiat Oncol Biol Phys 29(1):87-93.
8. Coleman CN, Urtasun RC, Wasserman TH, Hancock S, Harris JW, Halsey J, Hirst K. 1984. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. Int J Radiat Oncol Biol Phys 10(9):749-753.
9. Baxter LT, Jain RK. 1989. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res 37:77-104.
10. Robinson PJ, Rapoport SI. Blood brain barrier. In: Dulbecco FR, editor. Encyclopedia of human biology, vol. 1. San Diego: Academic Press, pp 716-727.
11. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohor G, Muller P, Morawetz R, Schold SC. 1995. Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012.
12. Brem H, Langer R. 1996. Polymer-based drug delivery to the brain. Sci Med 3(4):2-11.
13. Langer R. 1999. Selected advances in drug delivery and tissue engineering. J Control Release 62:7-11.
14. Donald T, Yapp T, Lloyd DK, Zhu J, Lehnert S. 1999. Radiosensitization of a mouse tumor model by sustained intra-tumoral release of Etanidazole and Tirapazamine using a biodegradable polymer implant device. Radiother Oncol 53:77-84.
15. Wang CH, Li J. 1998. Three dimensional simulation of IgG delivery to tumors. Chem Eng Sci 53(20):3579-3600.
16. Wang CH, Li J, Teo CS, Lee T. 1999. The delivery of BCNU to brain tumors. J Control Release 61:21-41.
17. Reisfeld B, Kalyanasundram S, Leong KW. 1995. A mathematical model of polymeric controlled drug release and transport in the brain. J Control Release 36:199-207.
18. Jain RK, Wei J. 1977. Dynamics of drug transport in solid tumors: Distributed parameter model. J Bioeng 1:313-330.
19. Netti PA, Baxter LT, Boucher Y, Skalak YR, Jain RK. 1995. Time-dependent behaviour of interstitial fluid pressure in solid tumors: Implication for drug delivery. Cancer Res 55:5451-5458.
20. Kalyansundaram S, Calhoun VD, Leong KW. 1997. A finite element model for predicting the distribution of drugs delivered intracranially to the brain. Am J Physiol 45(5):R1810-R1821.
21. Fung LK, Shin M, Tyler B, Brem H, Saltzman WM. 1996. Chemotherapeutic drugs released from polymers: Distribution of 1,3-bi(2-chloroethyl)-1-nitrosurea in the rat brain. Pharm Res 13(5):671-682.
22. Goodman GA, Rall TW, Nies AS, Taylor P. 1990. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, p 1221.
23. Tarmargo RJ, Myseros S, Epstein JI, Yang MB, Chasin M, Brem H. 1993. Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain. Cancer Res 53:329-333.
24. Wooding RA. 1957. Steady state free thermal convection of liquid in a saturated permeable medium. J Fluid Mech 2:273-285.
25. Wang FJ, Lee TKY, Wang CH. 2002. PEG modulated release of etanidazole from implantable PLGA/PLLA discs. Biomaterials 23:3555-3566.
26. Nagashima T, Horwitz B, Rapoport SI. 1990. A mathematical model for vasogenic brain edema. In: Long D, et al., editors. Advances in neurology, vol 52. New York: Raven Press, pp 317-325.
27. Nagashima T, Shirakuni T, Rapoport SI. 1990. A two-dimensional, finite element analysis of vasogenic brain edema. Neurol Med Chir (Tokyo) 30:1-9.
28. Nagashima T, Tada Y, Hamano S, Skakakura M, Masaoka K, Tamaki N, Matsumoto S. 1990. The finite element analysis of brain oedema associated with intracranial meningiomas. Acta Neurochir Suppl 51:155-157.
29. Patankar SV. 1980. Numerical heat transfer and fluid flow. Washington, DC: Hemisphere Publishing Corp.
30. Coleman NC, Halsey J, Cox RS, Hirst VK, Blaschke TE, Howes AE, Wasserman TH, Urtasun RC, Pajak T, Hancock S, Phillips TL, Noll L. 1987. Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile. Cancer Res 47:319-322.
31. Hall EJ. 1994. Radiobiology for the radiologist, 4th ed. Philadelphia: J.B. Lippincott Company, pp 165-178.
32. Conti B, Pavanetto F, Genta I, Giunchedi P. 1991. Solvent evaporation, solvent extraction and spray drying for polylactide microspheres preparation. Proceedings of 10th pharmaceutical technology conference, Bologna, pp 16-18.
33. Pavanetto F, Genta I, Giunchedi P, Conti B. 1993. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microspheres preparation. J Microencapsulat 10(4):487-497.
34. Strasser JF, Fung LK, Eller S, Grossman SA, Saltzman WM. 1995. Distribution of 1,3-bis(2-Chloroethyl)-1-Nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. J Pharmacol Exp Ther 275(3):1647-1655.